Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Inherent Targeting Logo
Inherent Targeting Growth Score
37
CB Rank
103051
Heat Score
73
Inherent Targeting develops fluorescent contrast agents that target nerves to improve surgical outcomes.
Founded
obfuscation
PrivatePre-Seed Portland, Oregon, United States1-10 www.inherenttargeting.com
Health Care
Medical
Medical Device
Overview

Inherent Targeting
Total Funding
obfuscation
Growth Score
37
Heat Score
73

Total Funding
obfuscation
Pre-Seed raised
obfuscation
Growth Score37
2 pts
in past quarter
Heat Score 73
-8 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Inherent Targeting

CB Rank
103051
Inherent Targeting develops fluorescent contrast agents that target nerves to improve surgical outcomes.
Founded
obfuscation
PrivatePre-Seed Portland, Oregon, United States1-10 www.inherenttargeting.com
Health Care
Medical
Medical Device

Funding Rounds

Pre-Seed
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

Details

Sub-Organization of 
Trace Biosciences Logo
Trace Biosciences
Legal Name Inherent Targeting, LLC
Operating Status Active
Company Type For Profit
Founders  Connor Barth, Lei Wang, Summer Gibbs
About the Company
Inherent Targeting develops fluorescent contrast agents that target nerves to improve surgical outcomes. The company was founded in 2019 and is headquartered in Portland, Oregon.
Phone Number 1 530-574-8435
Contact Email connor@inherenttargeting.com
Diversity Spotlight 
Women Founded
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Fluorescent Contrast Agents for Nerve Targeting
Fluorescent contrast agents designed to bind to nerves to enhance their visibility during surgery.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Pre Seed Round - Inherent Targeting Logo
Pre Seed Round - Inherent Targeting
1
obfuscation
— Pre-Seed
obfuscation
Pre Seed Round - Inherent Targeting Logo
Pre Seed Round - Inherent Targeting
1
obfuscation
— Pre-Seed
obfuscation
Pre Seed Round - Inherent Targeting Logo
Pre Seed Round - Inherent Targeting
1
obfuscation
— Pre-Seed
obfuscation
Pre Seed Round - Inherent Targeting Logo
Pre Seed Round - Inherent Targeting
1
obfuscation
— Pre-Seed
obfuscation
Pre Seed Round - Inherent Targeting Logo
Pre Seed Round - Inherent Targeting
1
obfuscation
— Pre-Seed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Pre Seed Round - Inherent Targeting Logo
Pre Seed Round - Inherent Targeting
1
obfuscation
— Pre-Seed
obfuscation
Pre Seed Round - Inherent Targeting Logo
Pre Seed Round - Inherent Targeting
1
obfuscation
— Pre-Seed
obfuscation
Pre Seed Round - Inherent Targeting Logo
Pre Seed Round - Inherent Targeting
1
obfuscation
— Pre-Seed
obfuscation
Pre Seed Round - Inherent Targeting Logo
Pre Seed Round - Inherent Targeting
1
obfuscation
— Pre-Seed
obfuscation
Pre Seed Round - Inherent Targeting Logo
Pre Seed Round - Inherent Targeting
1
obfuscation
— Pre-Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
SciFounders Logo
SciFounders
—
Pre Seed Round - Inherent Targeting Logo
Pre Seed Round - Inherent Targeting
—
SciFounders Logo
SciFounders
—
Pre Seed Round - Inherent Targeting Logo
Pre Seed Round - Inherent Targeting
—
SciFounders Logo
SciFounders
—
Pre Seed Round - Inherent Targeting Logo
Pre Seed Round - Inherent Targeting
—
SciFounders Logo
SciFounders
—
Pre Seed Round - Inherent Targeting Logo
Pre Seed Round - Inherent Targeting
—
SciFounders Logo
SciFounders
—
Pre Seed Round - Inherent Targeting Logo
Pre Seed Round - Inherent Targeting
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3

Employee Profiles

News
Technology
View Tech Report

IT Spend

$10.8KThis year, Inherent Targeting is projected to spend $10.8K on IT, according to Aberdeen.

Active Website Tech Count

3Inherent Targeting is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Euro.
Sub-Organizations
Frequently Asked Questions

Where is Inherent Targeting's headquarters? Inherent Targeting is located in Portland, Oregon, United States.Who invested in Inherent Targeting? Inherent Targeting has 2 investors including SciFounders and  National Science Foundation.When was the last funding round for Inherent Targeting? Inherent Targeting closed its last funding round on
obfuscation
from a Pre-Seed round.Who are Inherent Targeting's competitors? Alternatives and possible competitors to Inherent Targeting may include Acrivon Therapeutics, General Electric, and  Physical Sciences.How much funding has Inherent Targeting raised to date? Inherent Targeting has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(be4ac66 1)
|